SINCLAIR PHARMA PLC Sinclair Pharma plc - Notification of full year trading update
London, 05 January 2017 Sinclair Pharma plc (SPH.L), ('Sinclair') the international Aesthetics company, will be publishing a trading update for the year ending 31 December 2016 on 17 January 2017.
For further information please contact:
| Sinclair Pharma plc | Tel: +44 (0) 20 7467 6920 |
|
Chris Spooner
Alan Olby Andy Crane |
| Peel Hunt LLP (NOMAD and Broker) | Tel: +44 (0) 20 7418 8900 |
|
James Steel
Oliver Jackson |
Media enquiries
| FTI Consulting | Tel: +44 (0) 203 727 1000 |
|
Ben Atwell
Brett Pollard |
Download PDFhere
Notes to Editors:
About Sinclair Pharma plc
Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets and Brazil, and a network of international distributors.For more information, please visit www.sinclairpharma.com
Sinclair IS Pharma plc published this content on 05 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 January 2017 07:17:06 UTC.
Original documenthttp://www.sinclairpharma.com/notification-full-year-trading-update-1952
Public permalinkhttp://www.publicnow.com/view/3F93AA8492E7F537FC6DC0FE6988ABFA2757599D
